Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine Pharmaceutical Investing
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights Biotech Investing
BLU Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial Medical Device Investing
Wellteq Announces Partnership With Global Fitness and Wellness Marketplace, ClassPass Biotech Investing
BioHarvest Sciences Inc. to Launch E-Commerce Sales of VINIA in the United States on May 12, 2021 Biotech Investing
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
